A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis.
- 2023-01-03
- Proceedings of the National Academy of Sciences of the United States of America 120(2)
- Yuqing Wang
- Duolong Zhu
- Laura C Ortiz-Velez
- Jacob L Perry
- Michael W Pennington
- Joseph M Hyser
- Robert A Britton
- Christine Beeton
- PubMed: 36595694
- DOI: 10.1073/pnas.2211977120
- Low evidence
preferentially inhibit human T effector memory (TEM) lymphocyte proliferation in vitro
- Effect
- Beneficial
- Effect size
- Moderate